tert-Butyl cyclohexyl(3,4,5,6-tetrahydro-[2,3'-bipyridin]-6'-yl)carbamate

Catalog No. :
ACRNGR140
CAS No. :
1352496-42-4
Molecular Formula :
C21H31N3O2
Molecular Weight :
357.50

IUPAC Name:tert-butyl cyclohexyl(3,4,5,6-tetrahydro-[2,3'-bipyridin]-6'-yl)carbamate

tert-Butyl cyclohexyl(3,4,5,6-tetrahydro-[2,3'-bipyridin]-6'-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$987.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl cyclohexyl(3,4,5,6-tetrahydro-[2,3'-bipyridin]-6'-yl)carbamate
IUPAC Nametert-butyl cyclohexyl(3,4,5,6-tetrahydro-[2,3'-bipyridin]-6'-yl)carbamate
MDL No.MFCD20532391
Molecular FormulaC21H31N3O2
Molecular Weight357.50
SMILESO=C(OC(C)(C)C)N(C1CCCCC1)C2=CC=C(C3=NCCCC3)C=N2
InChI KeyCJJMMOCTWOKVBT-UHFFFAOYSA-N
SynonymCyclohexyl-(3,4,5,6-tetrahydro-[2,3]bipyridinyl-6-yl)-carbamic acid tert-butyl ester;tert-Butyl cyclohexyl(3,4,5,6-tetrahydro-[2,3'-bipyridin]-6'-yl)carbamate;Carbamic acid, N-cyclohexyl-N-(3,4,5,6-tetrahydro[2,3'-bipyridin]-6'-yl)-, 1,1-dimethylethyl ester
CAS No.1352496-42-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRNGR140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRNGR140 route product structure diagram
    ACRNGR1401352496-42-4
Inquiry

2. ACRNGR140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRNGR140 route product structure diagram
    ACRNGR1401352496-42-4
Inquiry

Comments (0)